|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 233.7 USD | +1.20% |
|
-1.92% | -4.15% |
Becton, Dickinson and Co. said it was continuing to work with the Food and Drug Administration on its remediation plan for the Alaris System. "Becton Dickinson Lowers FY20 Outlook, Cites Anticipated Loss of Alaris Sales," at 7:09 a.m. ET on Feb. 6, 2020, incorrectly referred to the FDA as the Federal Drug Administration.
(END) Dow Jones Newswires
06-18-21 1150ET
| 1st Jan change | Capi. | |
|---|---|---|
| -4.15% | 67.54B | |
| -5.60% | 181B | |
| -4.45% | 101B | |
| -8.63% | 45.09B | |
| +9.70% | 44.37B | |
| +6.13% | 40.7B | |
| +15.22% | 29.85B | |
| +14.80% | 24.49B | |
| -6.46% | 23.99B | |
| -10.82% | 22.33B |
BECTON, DICKINSON AND COMPANY 
